Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RCAN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V0E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGPAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP24-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
WRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL2BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK2AP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506098 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPYSL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GSE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORAI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on